Medigen Vaccine Biologics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Cash & Equivalents	120.26	715.61	1,393	1,204	1,380	1,679	Upgrade
Short-Term Investments	1,588	1,200	2,364	2,980	800	-	Upgrade
Trading Asset Securities	-	-	-	52.99	53.1	53.17	Upgrade
Cash & Short-Term Investments	1,708	1,916	3,757	4,237	2,233	1,733	Upgrade
Cash Growth	-3.85%	-49.02%	-11.33%	89.77%	28.87%	273.52%	Upgrade
Accounts Receivable	157.1	118.03	149.11	194.4	640.19	4.46	Upgrade
Other Receivables	9.91	9.98	49.74	1.17	0.07	126.25	Upgrade
Receivables	167.01	128.01	198.84	195.57	640.26	130.72	Upgrade
Inventory	508.16	452.06	383.64	903.4	610.84	77.43	Upgrade
Prepaid Expenses	17.05	20.44	13.49	12.37	32.29	17.3	Upgrade
Other Current Assets	44.52	40.79	48.14	113.89	205.07	51.64	Upgrade
Total Current Assets	2,445	2,557	4,401	5,462	3,721	2,010	Upgrade
Property, Plant & Equipment	1,311	1,354	1,385	1,470	1,414	1,343	Upgrade
Long-Term Investments	333.7	407.99	246.13	263.56	54	-	Upgrade
Other Intangible Assets	24.64	29.38	38.3	45.36	52.98	60.01	Upgrade
Other Long-Term Assets	22.27	16.07	22.36	106.83	57.26	77.71	Upgrade
Total Assets	4,136	4,364	6,093	7,348	5,299	3,491	Upgrade
Accounts Payable	12.65	13.39	25.89	109.1	88.53	21.78	Upgrade
Current Portion of Long-Term Debt	-	23.15	1,708	-	-	-	Upgrade
Current Portion of Leases	16.27	16.11	12	11.78	1.99	1.93	Upgrade
Current Unearned Revenue	-	-	-	-	111.41	-	Upgrade
Other Current Liabilities	149.59	161.57	245.73	234.35	237.15	137.27	Upgrade
Total Current Liabilities	178.51	214.22	1,992	355.23	439.09	160.98	Upgrade
Long-Term Debt	-	-	-	1,678	-	-	Upgrade
Long-Term Leases	291.48	299.7	254.36	266.35	183.87	185.85	Upgrade
Other Long-Term Liabilities	-	-	-	19.25	-	2.58	Upgrade
Total Liabilities	469.98	513.92	2,246	2,319	622.95	349.4	Upgrade
Common Stock	3,287	3,287	3,286	3,278	2,129	2,111	Upgrade
Additional Paid-In Capital	337.98	407.38	1,551	2,798	1,135	2,319	Upgrade
Retained Earnings	20.55	61.02	-1,018	-1,132	1,410	-1,292	Upgrade
Comprehensive Income & Other	19.81	94.25	27.85	84.03	1.92	3.27	Upgrade
Shareholders' Equity	3,666	3,850	3,847	5,029	4,676	3,141	Upgrade
Total Liabilities & Equity	4,136	4,364	6,093	7,348	5,299	3,491	Upgrade
Total Debt	307.75	338.96	1,974	1,956	185.85	187.78	Upgrade
Net Cash (Debt)	1,400	1,577	1,783	2,281	2,047	1,545	Upgrade
Net Cash Growth	-6.07%	-11.56%	-21.85%	11.45%	32.50%	-	Upgrade
Net Cash Per Share	4.30	4.80	5.43	7.05	6.37	5.57	Upgrade
Filing Date Shares Outstanding	332.96	328.73	328.61	327.84	315.67	313.02	Upgrade
Total Common Shares Outstanding	332.96	328.73	328.61	327.84	315.67	313.02	Upgrade
Working Capital	2,266	2,343	2,410	5,107	3,282	1,849	Upgrade
Book Value Per Share	11.01	11.71	11.71	15.34	14.81	10.04	Upgrade
Tangible Book Value	3,641	3,821	3,808	4,984	4,623	3,081	Upgrade
Tangible Book Value Per Share	10.94	11.62	11.59	15.20	14.65	9.84	Upgrade
Buildings	-	1,133	1,130	1,127	1,121	1,117	Upgrade
Machinery	-	686.4	650.64	626.59	570.9	388.46	Upgrade
Construction In Progress	-	2.57	21.37	14.54	4.7	17.54	Upgrade
Leasehold Improvements	-	9.35	3.34	3.03	2.55	1.89	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.